Cancer Biology Ph.D. Program
Admission Requirements
Stipends Students rollover
How to Apply
Curriculum
Seminar Series
Life in the Tampa Area
Contact Us
Entire Handbook

William Douglas Cress, Jr., Ph.D.
Associate Professor in the Interdisciplinary Oncology Program, Member-in-Residence of the Moffitt Cancer Center

E-mail: Douglas.Cress@moffitt.org
Phone: 813-745-6703
Web site: http://www.med.usf.edu/~dcress/

Training
B.S. Virginia Polytechnic Institute and State University, Biochemistry (Summa Cum Laude) 1986
Ph.D. Michigan State University, Biochemistry 1991
Postdoc. Fellow, Duke University Medical Center, Lab of Dr. Joseph Nevins 1991-1995

Research Interests
My laboratory is interested in understanding in the E2F transcription factor family that is thought to be one of the key regulators of cell growth and cell death. Presently, the laboratory has two major projects.

In the first project we are using DNA chip (or microarray) technology to identify genes that are regulated by members of the E2F family. Going into this project we knew that E2F1 could activate transcription of several genes and that its expression could drive DNA synthesis and, in higher doses, cell death. Surprisingly, in our microarray experiments we found that E2F-1 expression resulted in the transcriptional repression of numerous promoters. We are further investigating the numerous E2F-regulated promoters that we have identified to determine their roles in controlling cell proliferation and cell death.

A second project revolves around a novel member of the E2F family, E2F3B, which was identified by a graduate student in the lab. Because E2F3B is most abundant in cells that are quiescent, it is our hypothesis that E2F3B has a growth restraining activity. To test this hypothesis, we are using adenovirus vectors to express E2F3B to determine it affect on cell growth control relative to other member of the E2F family.

Search for publications by:   
This search will be conducted at the US National Library of Medicine (NLM) and PubMed.

Selected Publications

Croxton, R. L., Ma, Y., Song. L, Haura, E. B., and Cress, W. D. 2002. Repression of the Mcl-1 Promoter by E2F-1. Oncogene 21: 1359-1369.

Croxton, R. L., Ma, Y., and Cress, W. D. 2002. Distinct DNA Binding Properties Specify Repression of the Mcl-1 Promoter by E2F1, but not by E2F4. Oncogene 21: 1563-1570.

Ma, Y., Croxton, R. L., Moorer, Jr. R., and Cress, W. D. 2002. Identification of Novel E2F Regulated Genes by Microarray. Archive of Biochemistry and Biophysics 399:212-224

He, Y. and W.D. Cress. 2002. E2F-3B is a Physiological Target of Cyclin A. J. Biol. Chem. 277:23493-23499.

- Back to Main Faculty Page -

 


Cancer Biology Ph.D. Program
H. Lee Moffitt Cancer Center, MRC-4 East
12902 Magnolia Drive
Tampa, Florida 33612
Phone: 813-745-6876
E-mail: CancerPHD@moffitt.org
Copyright © 2000 University of South Florida

 

Moffitt Cancer Center University of South Florida Entire Handbook Contact Us Life in the Tampa Area Seminar Series Curriculum How to Apply Stipends Admission Requirements Faculty H.Lee Moffitt Cancer Center University of South Florida Cancer Biology Ph.D Program H.Lee Moffitt Cancer Center Faculty Cancer Biology Ph.D program at Moffitt